Selected research
Industry Research
Cefepime Injection Industry Research Report 2026
Market perspective
The global Cefepime Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cefepime Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cefepime Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cefepime Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cefepime Injection include Apotex, Meitheal Pharmaceuticals, Sagent, Samson Medical Technologies, WG Critical Care, Baxter, B Braun, Fresenius Kabi and Guangzhou Baiyunshan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cefepime Injection market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cefepime Injection Market by Company
Apotex
Meitheal Pharmaceuticals
Sagent
Samson Medical Technologies
WG Critical Care
Baxter
B Braun
Fresenius Kabi
Guangzhou Baiyunshan Pharmaceutical
Pfizer
Luoxin Group
Nanjing Hicin Pharmaceutical
Sandoz
Yuekang Pharmaceutical Group
Cefepime Injection Segment by Type
1g/50ml
2g/100ml
Cefepime Injection Segment by Application
Recovery Center
Hospital
Clinics
Cefepime Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefepime Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cefepime Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefepime Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cefepime Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cefepime Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cefepime Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1g/50ml
- 2g/100ml
Applications
- Recovery Center
- Hospital
- Clinics
Companies covered
- Apotex
- Meitheal Pharmaceuticals
- Sagent
- Samson Medical Technologies
- WG Critical Care
- Baxter
- B Braun
- Fresenius Kabi
- Guangzhou Baiyunshan Pharmaceutical
- Pfizer
- Luoxin Group
- Nanjing Hicin Pharmaceutical
- Sandoz
- Yuekang Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cefepime Injection Market Size (2021-2032)
- 2.2.2 Global Cefepime Injection Sales (2021-2032)
- 2.2.3 Global Cefepime Injection Market Average Price (2021-2032)
- 2.3 Cefepime Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1g/50ml
- 2.3.3 2g/100ml
- 2.4 Cefepime Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Recovery Center
- 2.4.3 Hospital
- 2.4.4 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cefepime Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cefepime Injection Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Cefepime Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Cefepime Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Cefepime Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cefepime Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cefepime Injection, Product Type & Application
- 3.8 Global Manufacturers of Cefepime Injection, Established Date
- 3.9 Global Cefepime Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Apotex
- 4.1.1 Apotex Company Information
- 4.1.2 Apotex Business Overview
- 4.1.3 Apotex Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Apotex Cefepime Injection Product Portfolio
- 4.1.5 Apotex Recent Developments
- 4.2 Meitheal Pharmaceuticals
- 4.2.1 Meitheal Pharmaceuticals Company Information
- 4.2.2 Meitheal Pharmaceuticals Business Overview
- 4.2.3 Meitheal Pharmaceuticals Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Meitheal Pharmaceuticals Cefepime Injection Product Portfolio
- 4.2.5 Meitheal Pharmaceuticals Recent Developments
- 4.3 Sagent
- 4.3.1 Sagent Company Information
- 4.3.2 Sagent Business Overview
- 4.3.3 Sagent Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sagent Cefepime Injection Product Portfolio
- 4.3.5 Sagent Recent Developments
- 4.4 Samson Medical Technologies
- 4.4.1 Samson Medical Technologies Company Information
- 4.4.2 Samson Medical Technologies Business Overview
- 4.4.3 Samson Medical Technologies Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Samson Medical Technologies Cefepime Injection Product Portfolio
- 4.4.5 Samson Medical Technologies Recent Developments
- 4.5 WG Critical Care
- 4.5.1 WG Critical Care Company Information
- 4.5.2 WG Critical Care Business Overview
- 4.5.3 WG Critical Care Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 WG Critical Care Cefepime Injection Product Portfolio
- 4.5.5 WG Critical Care Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Cefepime Injection Product Portfolio
- 4.6.5 Baxter Recent Developments
- 4.7 B Braun
- 4.7.1 B Braun Company Information
- 4.7.2 B Braun Business Overview
- 4.7.3 B Braun Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 B Braun Cefepime Injection Product Portfolio
- 4.7.5 B Braun Recent Developments
- 4.8 Fresenius Kabi
- 4.8.1 Fresenius Kabi Company Information
- 4.8.2 Fresenius Kabi Business Overview
- 4.8.3 Fresenius Kabi Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fresenius Kabi Cefepime Injection Product Portfolio
- 4.8.5 Fresenius Kabi Recent Developments
- 4.9 Guangzhou Baiyunshan Pharmaceutical
- 4.9.1 Guangzhou Baiyunshan Pharmaceutical Company Information
- 4.9.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
- 4.9.3 Guangzhou Baiyunshan Pharmaceutical Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Guangzhou Baiyunshan Pharmaceutical Cefepime Injection Product Portfolio
- 4.9.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Cefepime Injection Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 Luoxin Group
- 4.11.1 Luoxin Group Company Information
- 4.11.2 Luoxin Group Business Overview
- 4.11.3 Luoxin Group Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Luoxin Group Cefepime Injection Product Portfolio
- 4.11.5 Luoxin Group Recent Developments
- 4.12 Nanjing Hicin Pharmaceutical
- 4.12.1 Nanjing Hicin Pharmaceutical Company Information
- 4.12.2 Nanjing Hicin Pharmaceutical Business Overview
- 4.12.3 Nanjing Hicin Pharmaceutical Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Nanjing Hicin Pharmaceutical Cefepime Injection Product Portfolio
- 4.12.5 Nanjing Hicin Pharmaceutical Recent Developments
- 4.13 Sandoz
- 4.13.1 Sandoz Company Information
- 4.13.2 Sandoz Business Overview
- 4.13.3 Sandoz Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Sandoz Cefepime Injection Product Portfolio
- 4.13.5 Sandoz Recent Developments
- 4.14 Yuekang Pharmaceutical Group
- 4.14.1 Yuekang Pharmaceutical Group Company Information
- 4.14.2 Yuekang Pharmaceutical Group Business Overview
- 4.14.3 Yuekang Pharmaceutical Group Cefepime Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Yuekang Pharmaceutical Group Cefepime Injection Product Portfolio
- 4.14.5 Yuekang Pharmaceutical Group Recent Developments
5 Global Cefepime Injection Market Scenario by Region
- 5.1 Global Cefepime Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cefepime Injection Sales by Region: 2021-2032
- 5.2.1 Global Cefepime Injection Sales by Region: 2021-2026
- 5.2.2 Global Cefepime Injection Sales by Region: 2027-2032
- 5.3 Global Cefepime Injection Revenue by Region: 2021-2032
- 5.3.1 Global Cefepime Injection Revenue by Region: 2021-2026
- 5.3.2 Global Cefepime Injection Revenue by Region: 2027-2032
- 5.4 North America Cefepime Injection Market Facts & Figures by Country
- 5.4.1 North America Cefepime Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cefepime Injection Sales by Country (2021-2032)
- 5.4.3 North America Cefepime Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cefepime Injection Market Facts & Figures by Country
- 5.5.1 Europe Cefepime Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cefepime Injection Sales by Country (2021-2032)
- 5.5.3 Europe Cefepime Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Cefepime Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cefepime Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cefepime Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cefepime Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cefepime Injection Market Facts & Figures by Country
- 5.7.1 South America Cefepime Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cefepime Injection Sales by Country (2021-2032)
- 5.7.3 South America Cefepime Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cefepime Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cefepime Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cefepime Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cefepime Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cefepime Injection Sales by Type (2021-2032)
- 6.1.1 Global Cefepime Injection Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Cefepime Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Cefepime Injection Revenue by Type (2021-2032)
- 6.2.1 Global Cefepime Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cefepime Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Cefepime Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cefepime Injection Sales by Application (2021-2032)
- 7.1.1 Global Cefepime Injection Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Cefepime Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Cefepime Injection Revenue by Application (2021-2032)
- 7.2.1 Global Cefepime Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cefepime Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Cefepime Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cefepime Injection Value Chain Analysis
- 8.1.1 Cefepime Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cefepime Injection Production Mode & Process
- 8.2 Cefepime Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cefepime Injection Distributors
- 8.2.3 Cefepime Injection Customers
9 Global Cefepime Injection Analyzing Market Dynamics
- 9.1 Cefepime Injection Industry Trends
- 9.2 Cefepime Injection Industry Drivers
- 9.3 Cefepime Injection Industry Opportunities and Challenges
- 9.4 Cefepime Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst